Our Companies
Our in-house scientists and engineers build on original IP to launch and accelerate companies. Proven expertise and networks translate scientific discovery into commercial reality. Our unique strength is your secret weapon. To learn more information about our portfolio companies visit our companies page.
Newsworthy
Nature Cancer HIGHLIGHTS how mekanistic’s lead candidate, mtx-531, is poised to overcome cancer resistance
Invenshure CO-CEO talks medtech investing with Star Tribune
News and updates on Invenshure and our portfolio companies
Imbio Acquired by 4DMedical Creating Comprehensive Cardiothoracic Image Analysis Portfolio
CLICK TO LEARN MORE
dr. patricia lorusso joins MEKanistic scientific advisory board
click to Learn more
Our IP Partners
THE WORLD'S LEADING INSTITUTIONS AND MINDS
We nurture novel ideas and inventions, turning novel IP into powerful products and services.
